Vaccines and Related Biological Products Advisory Committee; Amendment of Notice-Selection of the 2024 to 2025 Formula for COVID-19 Vaccines

摘要

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Vaccines and Related Biological Products Advisory Committee. This meeting was announced in the Federal Register of March 4, 2024. The amendment is being made to reflect a change in the meeting date in the SUMMARY and DATES portions of the document from May 16, 2024, to June 5, 2024. There are no other changes.